Evaluation of the Effect of Eltrombopag on the Expression of Platelet Collagen Receptor Glycoprotein VI (GPVI) in Pediatric Patients With Chronic and Persistent Immune Thrombocytopenia.
Phase of Trial: Phase II
Latest Information Update: 22 Aug 2018
Price : $35 *
At a glance
- Drugs Eltrombopag (Primary) ; Azathioprine; Mycophenolate mofetil; Rituximab
- Indications Idiopathic thrombocytopenic purpura
- Focus Pharmacodynamics
- 31 Aug 2018 Biomarkers information updated
- 13 Aug 2018 Planned End Date changed from 1 Apr 2019 to 1 Nov 2019.
- 13 Aug 2018 Planned primary completion date changed from 1 Apr 2019 to 1 Nov 2019.